DiCorleto Paul E 4/A
4/A · CLEVELAND BIOLABS INC · Filed Apr 16, 2010
Insider Transaction Report
Form 4/AAmended
DiCorleto Paul E
Director
Transactions
- Award
Stock Options (Right to Buy)
2009-06-25+35,000→ 105,000 totalExercise: $3.33From: 2009-06-25Exp: 2019-06-24→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The exercise price of the stock options reported on the Form 4 filed on June 26, 2009 was incorrectly reported as $3.41. The actual exercise price of these stock options is $3.33. This amendment is being filed solely to correct the exercise price.